Evonetix
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
9a Coldham's Business Park Norman Way, C...Phone Number
+44 1223930300Website
www.evonetix.comRevenue
$6.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Evonetix
Evonetix is pioneering a novel approach to gene synthesis technology aimed at enhancing access to high-quality, gene-length DNA. Their innovative solutions are designed to empower researchers in various fields, including healthcare, agriculture, and manufacturing, by providing unprecedented speed and scale in gene synthesis. The company focuses on addressing critical global challenges through engineering biology, facilitating advancements in personalized medicine and other therapeutic areas. By establishing a gene foundry in every lab, Evonetix aims to accelerate the potential of engineering biology and drive significant innovations.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Evonetix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Evonetix
Website visits: Recent activity has been detected on your website
Evonetix, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Evonetix recently announced quarterly report
Click to see if Evonetix had a recent Job posting/layoffs
Check if Evonetix has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Evonetix has new funding data
Check out if Evonetix is spiking on competitors!
Product Launch: Get notified when Evonetix launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Evonetix
Compare insights from companies similar to Evonetix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Evonetix
$6.4M
51-200
Private
$66.3M
2015
N/A
Company Profile Activity
Activity Insights
Evonetix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Evonetix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Evonetix.
Evonetix financials insights
Gather financial insights about Evonetix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$12.3M
2023
Series B
$54M
Evonetix Tech Stack
A closer look at the technologies used by Evonetix
Most Recent Scoops
Funding
Open Position
New Hire
Executive Move
Evonetix has announced that Colin McCracken has joined the company as Chief Executive Officer. Previously, McCracken served as Senior Vice President & Chief Commercial Officer for Fluidigm.
Promotion
Executive Move
Funding
Funding
Evonetix News & Media
Evonetix Delivers First Chip-synthesized DNA to the University of Cambridge
CAMBRIDGE, England--(BUSINESS WIRE)--EVONETIX LTD (‘Evonetix’), the company bringing semiconductor technology to DNA synthesis, today announced that DNA synthesized using its unique semiconductor chip technology was delivered to the Department of Chemical Engineering and Biotechnology at the University of Cambridge. This milestone marks the start of the next stage of development of the Company as it expands the range and scale of DNA synthesized on its desktop platform. The DNA was delivered toMolten Ventures joins $54m funding round of biotech firm Evonetix - Silicon Republic
Molten Ventures has joined a $24m funding round extension of Evonetix, which is developing silicon chips to speed up the synthesis of DNA.Semiconductor tech firm raises £20m - BusinessCloud
Molten Ventures joined Foresite Capital and several other investors in Evonetix's fundraise for the development of their semiconductor chipsEvonetix Closes $24 Million USD (£20 Million) Financing
CAMBRIDGE, England--(BUSINESS WIRE)--EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 million financing round, extending its total series B funding to over USD $54 million (circa GB £44 million). This fundraise was led by existing investor Foresite Capital, with Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures and Providence also participating in the round. The
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Evonetix
Sign Up For FreeTo access detailed company insights
Evonetix is pioneering a novel approach to gene synthesis technology aimed at enhancing access to high-quality, gene-length DNA. Their innovative solutions are designed to empower researchers in various fields, including healthcare, agriculture, and manufacturing, by providing unprecedented speed and scale in gene synthesis. The company focuses on... Read More
